Navigation Links
ASGCT Selects First-Ever Career Development Grant Group, Awards $245,000 Total
Date:1/8/2019

The American Society of Gene and Cell Therapy’s (ASGCT) first class of 14 career development grant recipients were named by a selection committee made up of industry leaders identified by the ASGCT board of directors. In total, the Society will distribute $245,000.

The Career Development grants are mentored awards created to support ASGCT members designing transformative pilot studies in gene and cell therapy as they prepare to transition to independence. The Society was particularly interested in funding ideas that would be challenging to fund with normal mechanisms and helping applicants generate preliminary data to use in larger proposals (NIH K awards, first-submission R-level funding, etc.).

ASGCT’s 14 inaugural awardees are a diverse group from varied and wide-ranging specialties:

Ulrika Beitnere, Ph.D.—University of California Davis, Department of Biochemistry and Molecular Medicine
Realizing the dream of RNA-directed Therapies by Combinatorial Assessment of Cas13 Family Nucleases and AAV Delivery to the Brain

Diana X. Bharucha-Goebel, M.D.—Children’s National Health System and The George Washington University School of Medicine and Health Sciences
A systematic clinical analysis of the immunologic effects of intrathecal AAV9 mediated gene transfer targeting the central nervous system

Lauriel F. Earley, Ph.D.—University of Chapel Hill – North Carolina, Gene Therapy Center, Department of Pediatrics
Development of a novel innate-immune evasive AAV-Pank2 vector for treatment of PKAN

Mohamed A. Hammad, Ph.D.—Beckman Research Institute of the City of Hope
A Novel Neural Stem Cell-Mediated Oncolytic Chimeric Pox Virotherapy for Stage III Ovarian Cancer

Geoffrey D. Keeler—University of Florida, Department of Pediatrics, Division of Cellular & Molecular Therapy
Identifying optimal CD8 Treg for CAR Treg Therapy

Makan Khoshnejad Ph.D.—The Wistar Institute, The Vaccine Center
DNA-encoded Bispecific LDL Engager (BiLE) antibodies for treatment of hypercholesterolemia

Benjamin Kleinstiver, Ph.D.—Massachusetts General Hospital
Enhancing the Safety of CRISPR-Engineered T cells for Cancer Immunotherapy

Ami Patel, Ph.D.—The Wistar Institute, Vaccine and Immunotherapy Center
In vivo post-translational glycoengineering of plasmid DNA gene-encoded monoclonal antibodies

Nicole Paulk, Ph.D.—University of California San Francisco, Department of Biochemistry & Biophysics
Characterizing the proteomic landscape of rAAV vectors for human liver gene therapies

Sandhya Sharma—Baylor College of Medicine, Center for Cell and Gene Therapy
Generation of memory cell enriched, broad repertoire antigen specific T cells for EBV positive malignancies

Katie M. Stiles, Ph.D.—Weill Cornell Medical College, Genetic Medicine
Modification of AAV expression vectors to enhance translation

Lauren E. Woodard, Ph.D.—Vanderbilt University Medical Center, Division of Nephrology and Hypertension, Department of Medicine
Treatment of acute kidney injury via in situ reprogramming

Mehmet E Yalvac, Ph.D.—The Ohio State University Wexner Medical Center
Generation of motor neurons carrying ALS-associated KIF5A mutations from gene edited embyonic stem cells

Jiehua Zhou, Ph.D.—Beckman Research Institute of the City of Hope National Medical Center
Targeting HIV-1 Reservoirs by Multi-specific Aptamers-based T cells Engager (MATE)

ASGCT is honored to have received such strong interest from its membership and congratulates this strongly-qualified group of awardees. The 2019 Career Development Grants program will begin accepting applications shortly after the 22nd ASGCT Annual Meeting, April 29 – May 2, held at the Washington Hilton in Washington, D.C.

About ASGCT
The American Society of Gene & Cell Therapy is the primary professional membership organization for scientists, physicians, patient advocates, and other professionals with interest in gene and cell therapy. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, biotechnology and pharmaceutical companies. ASGCT advances knowledge, awareness, and education leading to the discovery and clinical application of gene and cell therapies to alleviate human disease to benefit patients and society.

Read the full story at https://www.prweb.com/releases/asgct_selects_first_ever_career_development_grant_group_awards_245_000_total/prweb16018219.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
2. Top Genetic and Cellular Researchers Honored at ASGCT 16th Annual Meeting
3. ASGCT Presidential Symposium to Feature Laureates of the Prestigious 2015 Japan Prize
4. Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
5. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
6. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
7. NASA Selects 31 Space Biology Research Proposals
8. Medical Design Excellence Awards Selects Companion 2 Hospital Driver for Powering SynCardia Total Artificial Heart as Silver Winner
9. Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software for Improved Quality Control and Regulatory Compliance
10. KBI Biopharma Selects Freeslate’s Biologics Formulation System for Early and Late Stage Drug Development
11. NASA Selects 11 Space Radiobiology Research Proposals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life ... cells in blood, has been named as a partner in Medigen Biotech’s upcoming ... cell therapies for cancer treatment, will use CellMax Life’s circulating tumor cell platform ...
(Date:12/19/2018)... ... 19, 2018 , ... R3 Stem Cell is now offering ... in Las Vegas. Training includes facial rejuvenation, hair restoration and erectile dysfunction procedures ... aesthetics, having the training from expert, Board Certified providers is critical to instilling ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM Life Sciences, the leading ... industry, unveiled a completely redesigned website at http://www.usdm.com . The site offers ... their valued clients and business partners. , The website has a revamped ...
(Date:12/13/2018)... ... December 11, 2018 , ... Researchers at ... use to quickly detect Clostridium difficile (C. diff), a dangerous and sometimes fatal ... device that can be used onsite in doctor’s offices and nursing homes, providing ...
Breaking Biology Technology:
(Date:12/19/2018)... CITY, N.Y. (PRWEB) , ... December 19, 2018 , ... ... the most innovative products in healthcare for 2018. , PM360 is featuring the ... most innovative products and services offered to the pharmaceutical and medical device industries. ...
(Date:12/18/2018)... ... 18, 2018 , ... Nativis, Inc. , a clinical ... today announced the publication of an early feasibility study in CNS Oncology suggesting ... The publication of the study, An Early Feasibility Study of the Nativis Voyager® ...
(Date:12/13/2018)... ... 13, 2018 , ... Study Protocol Summary of QC Procedure , 1 – ... assessment performed at the site., 3 - Three photos captured with Apple iPad and ... BOX., 5 - Photos moved to eAdjudication® and submitted to Reviewers., 6 - ...
Breaking Biology News(10 mins):